The Real Cost of Wegovy: Insurance, GoodRx, and Manufacturer Coupons Compared
How much does Wegovy actually cost in 2026? We break down list price, insurance co-pays, the Novo Nordisk savings card, GoodRx, and compounded alternatives side by side.
By GLP Watchdog Editorial Team
Medical reviewer: pending. A board-certified MD is being engaged to review everything clinical here. Our methodology sets out how these guides get researched and kept current.
Looking for a provider? Our 2026 comparison of the leading GLP-1 telehealth sellers is a click away.
Savings Calculator →Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wegovy's list price is $1,349.02 per 28-day supply. Almost nobody actually pays that — but the real price you'll pay is maddeningly hard to predict because it depends on your insurance plan, your employer's formulary, your state's pharmacy discount rules, and whether you qualify for the manufacturer's savings card. This guide walks through every pricing path, with real numbers, and tells you which ones are worth pursuing.
If you already know your insurance won't cover weight-loss drugs and you want the fastest answer, jump to our GLP-1 savings calculator — it'll estimate your monthly cost based on your insurance type and preferred medication. Otherwise, read on.
Key Takeaways
- List price: $1,349.02/month (Novo Nordisk, verified early 2026)
- With commercial insurance that covers Wegovy: typically $25–$200/month after prior authorization
- With commercial insurance that does NOT cover Wegovy: Novo Nordisk savings card can bring cost to $499/month for up to 13 fills
- With Medicare: generally not covered for weight loss (limited exception for cardiovascular indication)
- GoodRx for Wegovy: rarely useful — coupons typically knock off only $10–$50
- Compounded semaglutide: $129–$249/month with no insurance hassle
- Annual cost range: $300 (best insurance) to $16,188 (full list price)
The Headline Number: $1,349.02
Novo Nordisk's published list price ("wholesale acquisition cost" or WAC) for Wegovy is $1,349.02 per 28-day supply, which works out to roughly $16,188 per year if you pay list for 12 months. This is the price before any insurance, discount card, or manufacturer program is applied.
Dose makes no difference to list price. A pen box costs the same at 2.4 mg as it does at 1.7 mg, 1.0 mg, 0.5 mg or 0.25 mg. That's a deliberate manufacturer pricing strategy. It means a patient in month 1 (starting dose) and month 8 (maintenance dose) both pay the same retail price.
Verify the current price directly on Wegovy.com. Prices change quarterly.
Path 1: Commercial Insurance That Covers Wegovy
If your employer-sponsored or marketplace insurance plan includes Wegovy on its formulary for obesity treatment, you'll typically pay a tiered co-pay after meeting any deductible. Typical ranges:
| Plan type | Monthly co-pay range |
|---|---|
| Preferred brand (Tier 2) | $25 – $50 |
| Non-preferred brand (Tier 3) | $60 – $150 |
| Specialty tier (Tier 4) | $150 – $350 |
| High-deductible plan, pre-deductible | Full list price until deductible met |
The catch: almost every plan that covers Wegovy requires prior authorization (PA). Typical PA criteria include:
- BMI at ≥30, or ≥27 carrying a documented comorbidity — dyslipidemia, sleep apnea, hypertension or type 2 diabetes
- Documentation of a prior structured weight-loss attempt (often 6 months of diet and exercise notes)
- No contraindications (thyroid cancer history, pancreatitis, etc.)
- Reauthorization every 6–12 months with documented weight loss
For details on which insurers cover Wegovy and how to navigate the PA process, see our state-by-state insurance breakdown or the research article on GLP-1 coverage across commercial plans, Medicaid and Medicare.
Path 2: Commercial Insurance That Does NOT Cover Wegovy
This is the most common situation in 2026. Roughly 65–70% of commercial plans still exclude GLP-1 drugs when prescribed for obesity. If you have commercial insurance but your plan excludes Wegovy, you have one excellent option: the Novo Nordisk Wegovy Savings Card.
The Novo Nordisk Savings Card
As of early 2026, the Wegovy Savings Card offers commercially insured patients whose insurance does NOT cover Wegovy a fixed price of $499/month for up to 13 fills (approximately one year). Eligibility requirements:
- Commercial/private insurance only (no Medicare, Medicaid, TRICARE, VA, or government plans)
- Wegovy must be prescribed for an on-label use
- You must enroll directly through Wegovy.com or at your pharmacy
- The card cannot be combined with other discount cards or coupons
For commercially insured patients whose plan *does* cover Wegovy, a separate version of the card can reduce co-pays as low as $0 for up to 13 fills, with a maximum monthly benefit typically capped around $225.
We cover this and the Eli Lilly equivalent in detail in our manufacturer coupons guide.
Path 3: Medicare and Medicaid
Medicare Part D has kept weight-loss drugs out by statute for most of its history. Since 2024, on the strength of the SELECT cardiovascular indication, Medicare will cover Wegovy where a patient has established cardiovascular disease together with obesity or overweight. For weight loss alone, Medicare still does not cover Wegovy.
Medicaid coverage varies wildly by state. Roughly 15 states cover Wegovy for obesity through their Medicaid programs, often with strict PA requirements. Others cover it only for diabetes (meaning Ozempic only). We maintain a state-by-state list in our insurance coverage breakdown.
Path 4: GoodRx and Discount Cards (Mostly a Dead End)
GoodRx, SingleCare, and similar discount cards work well for generic drugs. They work poorly for brand-name GLP-1s. As of early 2026, the typical GoodRx Wegovy price is $1,290–$1,340 — a savings of roughly $10–$60 off list. The current GoodRx Wegovy page is worth checking, but don't expect miracles.
The structural reason: GoodRx negotiates with pharmacy benefit managers on cash-pay pharmacy rates. Those rates for brand-name GLP-1s are already set close to list because the drugs are in high demand and manufacturers don't offer deep cash-pay discounts. Compare this to a generic like metformin, where GoodRx can knock 80% off retail.
Bottom line: don't skip the savings card in favor of GoodRx for Wegovy. The manufacturer card is dramatically better.
Path 5: Compounded Semaglutide
Compounded semaglutide is the same active ingredient as Wegovy, produced by licensed 503A or 503B pharmacies and dispensed through telehealth providers. It's not "Wegovy" (it doesn't use Novo Nordisk's formulation, and it's not FDA-approved as a finished drug product), but the molecule is identical.
Typical monthly costs for compounded semaglutide from reputable providers:
| Provider | Typical monthly cost |
|---|---|
| CoreAge Rx | $149 |
| Hims | $199 |
| Henry Meds | $297 |
| Ro | $229 |
| Mochi Health | $229 |
See our full best GLP-1 providers ranking for up-to-date pricing and reviews. Before choosing compounded, read our safety explainer on compounded semaglutide — not every compounder is reliable.
Putting It All Together: Annual Cost Scenarios
| Scenario | Monthly | Annual |
|---|---|---|
| Best case: insurance covers, $25 co-pay | $25 | $300 |
| Good case: insurance covers, $100 co-pay | $100 | $1,200 |
| Savings card + commercial insurance not covering | $499 | $6,487 |
| Compounded semaglutide via telehealth | $149–$299 | $1,788 – $3,588 |
| Full list price, no discounts | $1,349 | $16,188 |
The spread is enormous. The same molecule can cost you $300/year or $16,000/year depending on how you access it.
Pros and Cons of Each Path
Insurance-covered Wegovy:
- Pro: Cheapest option when it works; FDA-approved brand
- Con: PA hassle; still unavailable for most plans; can be discontinued if you lose coverage
Savings card ($499/mo):
- Pro: Brand-name drug, predictable pricing, no insurance arguments
- Con: Limited to 13 fills; commercial insurance requirement; still expensive
Compounded semaglutide:
- Pro: Dramatically cheaper; fast telehealth access; no PA
- Con: Not FDA-approved as finished product; quality varies by pharmacy; ongoing regulatory uncertainty
GoodRx / discount cards:
- Pro: Worth a 30-second check
- Con: Almost never meaningful for brand GLP-1s
How to Actually Navigate This
- Call your insurer first. Ask specifically: "Is Wegovy on my formulary for obesity treatment? What's the PA requirement? What's my tier and co-pay?"
- If covered: work with your prescriber to file the PA. Budget 2–4 weeks.
- If not covered but commercially insured: enroll in the Novo Nordisk savings card at Wegovy.com.
- If you want a lower price point: compare compounded semaglutide providers in our best providers ranking.
- Always check real prices: use the live price tracker before committing.
Bottom Line
There is no single "Wegovy cost." There is a range — from $300 a year to over $16,000 a year — and which end you land on depends almost entirely on the path you take. For most patients without generous GLP-1 coverage, the practical choice in 2026 is between the Novo Nordisk savings card ($499/month) and compounded semaglutide ($149–$299/month) from a reputable telehealth provider.
Before you commit, model your actual cost using our savings calculator and read our research breakdown of GLP-1 insurance coverage to understand which insurers and plan types typically cover Wegovy. For a deeper look at the related question of who actually covers Wegovy, read does insurance cover Wegovy.
Sources & methodology — as of April 2026
- 1.NovoCare — Wegovy cash-pay and savings program— Novo Nordisk (NovoCare).
- 2.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 3.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
Ready to compare GLP-1 providers?
Trust, support, availability, the medications carried and what they cost — we rank every major telehealth seller on all five, and refresh it each quarter. Nothing padded.
Savings Calculator →Related guides
How to Get GLP-1 Without Insurance: Complete 2026 Guide
Complete guide to accessing semaglutide, tirzepatide, and other GLP-1 weight loss medications without insurance — compounded options, manufacturer coupons, and the cheapest legal paths.
Ozempic vs Wegovy: Same Drug, Different Prices — Here's Why
One molecule, semaglutide, sold under two names at different doses and approved by the FDA for different things. We explain the pricing arbitrage and which to choose.
Manufacturer Coupons for Ozempic, Wegovy, Mounjaro, and Zepbound
A current guide to the Novo Nordisk and Eli Lilly savings card programs — who qualifies, how much you save, and the fine print most patients miss.
Does Insurance Cover Wegovy? State-by-State Breakdown
A practical guide to Wegovy insurance coverage in 2026 — which major carriers cover it, what prior authorization looks like, and how Medicaid coverage varies by state.
Read our methodology · affiliate disclosure · about us